ACCO has gapped higher on the last two releases (7/30/14 & 10/29/14) after beating EPS estimates by 12% & 20% respectively. The stock is consolidating once again prior to , and looks conducive to a third gap when they release on February 11th. This looks like an optimal trading entry, as there looks like there is support around the $8 level.
Stock also showing strong price momentum recently (+31% in last six months) and looks strongly undervalued on a relative basis ( yield of 10% & sales yield of 185%). Short interest is a little high at 8%, and it looks like here has been some insider and institutional selling recently. Overall, our factor analysis model expects the stock to outperform the market by 14% over the next twelve months, mainly due to undervaluation & momentum.